ACADIA Pharmaceuticals Inc (ACAD)
17.05
-0.03
(-0.18%)
USD |
NASDAQ |
May 03, 16:00
17.06
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals Accounts Receivable (Quarterly): 98.27M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 98.27M |
September 30, 2023 | 92.80M |
June 30, 2023 | 81.85M |
March 31, 2023 | 65.92M |
December 31, 2022 | 62.20M |
September 30, 2022 | 55.73M |
June 30, 2022 | 67.95M |
March 31, 2022 | 62.71M |
December 31, 2021 | 64.37M |
September 30, 2021 | 60.70M |
June 30, 2021 | 51.37M |
March 31, 2021 | 56.83M |
December 31, 2020 | 48.25M |
September 30, 2020 | 46.34M |
June 30, 2020 | 43.78M |
March 31, 2020 | 41.64M |
December 31, 2019 | 35.78M |
September 30, 2019 | 30.80M |
June 30, 2019 | 31.78M |
March 31, 2019 | 29.96M |
December 31, 2018 | 26.09M |
September 30, 2018 | 19.96M |
June 30, 2018 | 25.70M |
March 31, 2018 | 22.44M |
December 31, 2017 | 17.34M |
Date | Value |
---|---|
September 30, 2017 | 14.22M |
June 30, 2017 | 11.59M |
March 31, 2017 | 7.66M |
December 31, 2016 | 5.903M |
September 30, 2016 | 3.839M |
June 30, 2016 | 0.293M |
March 31, 2016 | |
December 31, 2015 | 0.00 |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
30.80M
Minimum
Sep 2019
98.27M
Maximum
Dec 2023
57.85M
Average
56.83M
Median
Mar 2021